Pop up content
How pharmaceuticals can get the most out of and reduce downtime
The age of the blockbuster drug is over. The last remnants of this golden age of pharmaceuticals are slowly coming out of IP protection and being mass produced by a large range of companies. As a new day dawns on the pharmaceutical industry, Gayle Walker, operations manager at Novotek UK & Ireland, explains what pharmaceutical companies can do to prevent unnecessary downtime in production and raise production efficiency.
Plans to integrate digitalisation across the globe have led many governments to set-out initiatives to accelerate the rate of adoption over the next 10 to 20 years. Here, George Walker, managing director of industrial IT and automation provider Novotek explains why businesses should be looking to digitalise their systems sooner rather than later.